BrainsWay Announces Innovative Deep Transcranial Magnetic Stimulation System Showcase Presentation at this Year’s Psych Congress Meeting
01 oct. 2019 09h00 HE
|
BrainsWay Ltd.
JERUSALEM, Oct. 01, 2019 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ: BWAY, TASE: BWAY), a global leader in the advanced non-invasive treatment of brain disorders, announced today they will be...
Achieve TMS East Celebrates the Opening of a New Office in West Hartford, Connecticut
24 sept. 2019 09h00 HE
|
BrainsWay Ltd.
WEST HARTFORD, Conn., Sept. 24, 2019 (GLOBE NEWSWIRE) -- Achieve TMS East, New England’s largest provider of Deep Transcranial Magnetic Stimulation (Deep TMS) therapy for the treatment of major...
BrainsWay Announces Further Leadership Transition to U.S.
19 sept. 2019 10h10 HE
|
BrainsWay Ltd.
JERUSALEM and HACKENSACK, N.J., Sept. 19, 2019 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced, non-invasive treatment of...
Brainsway Reports Second Quarter 2019 Financial Results and Operational Highlights
26 août 2019 06h30 HE
|
BrainsWay Ltd.
JERUSALEM, Israel and HACKENSACK, N.J., Aug. 26, 2019 (GLOBE NEWSWIRE) -- Brainsway Ltd. (NASDAQ & TASE: BWAY) (“Brainsway” or the “Company”), a global leader in the advanced non-invasive...
BrainsWay Ltd. to Host Second Quarter 2019 Financial Results Conference Call on August 26, 2019
14 août 2019 08h00 HE
|
BrainsWay Ltd.
JERUSALEM and HACKENSACK, N.J., Aug. 14, 2019 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive treatment of...
Achieve TMS East Celebrates the Opening of its Haverhill Location
25 juil. 2019 09h00 HE
|
BrainsWay Ltd.
HAVERHILL, Mass., July 25, 2019 (GLOBE NEWSWIRE) -- Achieve TMS East, Massachusetts’ largest provider of deep TMS therapy for the treatment of Depression and OCD, is pleased to announce the opening...
Groundbreaking Study Demonstrates Advantages of BrainsWay Deep TMS in Treating Major Depressive Disorder
18 juil. 2019 07h00 HE
|
BrainsWay Ltd.
- First head-to-head, randomized controlled trial of its kind comparing Deep TMS, TMS and medication in depression patients published in July issue of the Journal of Psychiatric Research - ...
New Data Published in American Journal of Psychiatry Further Substantiates BrainsWay’s Deep TMS System for the Treatment of Patients with Obsessive Compulsive Disorder
27 juin 2019 10h01 HE
|
BrainsWay Ltd.
- First non-invasive device for OCD achieves 45% response rate among patients after one month follow up, and significantly reduced symptoms scores compared with placebo - HACKENSACK, N.J., June 27,...
Brainsway Announces Changes to its Board of Directors
17 juin 2019 07h00 HE
|
BrainsWay Ltd.
JERUSALEM, Israel and HACKENSACK, N.J., June 17, 2019 (GLOBE NEWSWIRE) -- Brainsway Ltd. (NASDAQ & TASE: BWAY) (Brainsway), a commercial stage medical device company focused on the development...
BrainsWay to Present at the 2019 Raymond James Life Sciences and MedTech Conference
13 juin 2019 07h00 HE
|
BrainsWay Ltd.
JERUSALEM and HACKENSACK, N.J., June 13, 2019 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE:BWAY) (BrainsWay” or the “Company”), a commercial stage medical device company focused on the...